ROUND CELL LIPOSARCOMA
Clinical trials for ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a booster shot for immune cells fight rare sarcomas?
Disease control Recruiting nowThis early study tests an immunotherapy drug called N-803 in 8 people with rare soft-tissue sarcomas (synovial sarcoma or myxoid/round cell liposarcoma) whose cancer got worse after a prior cell therapy. N-803 aims to wake up leftover immune cells from the earlier treatment so th…
Matched conditions: ROUND CELL LIPOSARCOMA
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New combo therapy aims to halt rare cancer growth
Disease control Recruiting nowThis study tests whether two drugs, mirdametinib and palbociclib, can safely control advanced liposarcoma that has spread or cannot be removed by surgery. About 54 adults with this rare cancer will receive different doses to find the best balance of safety and effectiveness. The …
Matched conditions: ROUND CELL LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC